Overview

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)

Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of G-CSF on disease free survival and overall survival in aplastic anaemia patients who also receive ATG and Cyclosporin A.
Phase:
Phase 3
Details
Lead Sponsor:
European Group for Blood and Marrow Transplantation
European Society for Blood and Marrow Transplantation
Collaborator:
CHUGAI sanofi-aventis
Treatments:
Cyclosporine
Cyclosporins
Lenograstim